The increased level of CXCR4 and its canonical ligand CXCL12 (SDF-1α) is frequently found to be elevated in metastatic sites of many cancers, including breast cancer, pancreatic cancer, or cervical/ovarian carcinoma [81]. Here, CXCL12 is linked to pancreatic neoplasm.